Review
Eye (2004) 18, 1225–1234. doi:10.1038/sj.eye.6701383 Published online 16 April 2004
Ophthalmic management of facial nerve palsy
V Lee1, Z Currie2 and J R O Collin3
- 1Central Eye Service, Central Middlesex Hospital, Acton Lane, Park Royal Acton, London, UK
- 2Department of Ophthalmology, Royal Hallamshire Hospital, Glossop Road, Sheffield, UK
- 3Moorfields Eye Hospital, City Road, London, UK
Correspondence: Miss V Lee, MA, FRCOphth Consultant Ophthalmic Surgeon, Central Eye Service, Central Middlesex Hospital, Acton Lane, Park Royal, London NW10 7NS, UK. Tel: 02084532435; Fax: 02084532404; E-mail: vickielee@mac.com
The authors have no financial or proprietary interest in this study.
Received December 2003; Accepted 6 November 2003; Published online 16 April 2004.
Abstract
The ophthalmologist plays a pivotal role in the evaluation and rehabilitation of patients with facial nerve palsy. It is crucial to recognize and treat the potentially life-threatening underlying causes. The immediate ophthalmic priority is to ensure adequate corneal protection. The medium to long-term management consists of treatment of epiphora, hyperkinetic disorders secondary to aberrant regeneration and poor cosmesis. Patients should be appropriately referred for general facial re-animation. This review aims to provide a guide to the management of this complex condition.
Keywords:
gold weight, tarsorrhapy, facial reanimation, lagophthalmos, aberrant regeneration, epiphora
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
